HAE
Haemonetics·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
HAE Filings
Filing Date
Form Description
Form Type
2025-11-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-06
Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-06
Form 8-K - Current report
Key Events
2025-11-06 · Key Events
Form 8-K - Current report
2025-11-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-09-24
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-09-24 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-08-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-07
Haemonetics (HAE)-7 Aug 25-2026 Q1 Earnings call transcript
Earnings Call
2025-08-07 · Earnings Call
Haemonetics (HAE)-7 Aug 25-2026 Q1 Earnings call transcript
2025-08-07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-07 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-07
Form 8-K - Current report
Key Events
2025-08-07 · Key Events
Form 8-K - Current report
